Abstract

Neutrophils are increasingly implicated in chronic inflammation and metabolic disorders. Here, we show that visceral adipose tissue (VAT) from individuals with obesity contains more neutrophils than in those without obesity and is associated with a distinct bacterial community. Exploring the mechanism, we gavaged microbiome-depleted mice with stool from patients with and without obesity during high-fat or normal diet administration. Only mice receiving high-fat diet and stool from subjects with obesity show enrichment of VAT neutrophils, suggesting donor microbiome and recipient diet determine VAT neutrophilia. A rise in pro-inflammatory CD4+ Th1 cells and a drop in immunoregulatory T cells in VAT only follows if there is a transient spike in neutrophils. Human VAT neutrophils exhibit a distinct gene expression pattern that is found in different human tissues, including tumors. VAT neutrophils and bacteria may be a novel therapeutic target for treating inflammatory-driven complications of obesity, including insulin resistance and colon cancer.

The role of neutrophils is increasingly being recognized in chronic inflammation and metabolic disorders. Here the authors show that visceral adipose tissue from individuals with obesity contains more neutrophils than in those without obesity and is associated with a distinct bacterial community.

Details

Title
Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils
Author
Shantaram, Dharti 1   VIAFID ORCID Logo  ; Hoyd, Rebecca 2 ; Blaszczak, Alecia M. 1 ; Antwi, Linda 2 ; Jalilvand, Anahita 1 ; Wright, Valerie P. 1 ; Liu, Joey 1 ; Smith, Alan J. 1 ; Bradley, David 1 ; Lafuse, William 3 ; Liu, YunZhou 2   VIAFID ORCID Logo  ; Williams, Nyelia F. 2   VIAFID ORCID Logo  ; Snyder, Owen 2 ; Wheeler, Caroline 2 ; Needleman, Bradley 4 ; Brethauer, Stacy 4 ; Noria, Sabrena 4 ; Renton, David 4 ; Perry, Kyle A. 4 ; Nagareddy, Prabha 5 ; Wozniak, Daniel 3   VIAFID ORCID Logo  ; Mahajan, Sahil 3 ; Rana, Pranav S. J. B. 3   VIAFID ORCID Logo  ; Pietrzak, Maciej 6 ; Schlesinger, Larry S. 7   VIAFID ORCID Logo  ; Spakowicz, Daniel J. 2   VIAFID ORCID Logo  ; Hsueh, Willa A. 1   VIAFID ORCID Logo 

 Wexner Medical Center at The Ohio State University, Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
 Pelotonia Institute for Immuno-Oncology at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA (GRID:grid.413944.f) (ISNI:0000 0001 0447 4797) 
 The Ohio State University, Department of Microbial Infection and Immunity, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
 The Ohio State University, Center for Minimally Invasive Surgery, Department of General Surgery, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
 Cardiovascular Section University of Oklahoma Health Sciences Center (OUHSC), Department of Internal Medicine, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618) 
 The Ohio State University, Department of Biomedical Informatics, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943) 
 Texas Biomedical Research Institute, Host Pathogen Interactions Program, San Antonio, USA (GRID:grid.250889.e) (ISNI:0000 0001 2215 0219) 
Pages
5434
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3072928023
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.